-
The University of Pennsylvania’s new texting program, called COVID Watch, could play a key role in the future of monitoring COVID-19 patients after discharge. The program sends automated text messages in English and Spanish twice a day for 14 days, asking patients if their symptoms are better, the same, or worse.
-
After 18 months of the COVID-19 pandemic, hospitals are learning how to efficiently and safely transition these patients to community settings. For example, one study showed an ED and hospital patient throughput management program can save hundreds of hospital patient days after discharge from the ED or observation unit stays.
-
We are excited to announce Hospital Case Management will now be expanded to include content from Case Management Advisor, bringing you even more relevant content and continuing education at no additional cost.
-
In one emergency department, more than three-quarters of all healthcare workers said they experienced a violent assault in the prior 12 months.
-
IRBs can resolve most research-related complaints, but a policy implemented last year by the National Institutes of Health’s Office of Human Subjects Research Protections offers assistance when the conflict reaches a stalemate.
-
An associate professor at Columbia Law School in New York City wrote about the handling of research grievances from research studies. The processes for resolving research participants’ concerns are a “curiously unregulated space." While the United States court system might recognize claims about physical injuries during a trial or a negligent study design, it usually is left to the IRB to resolve disputes between trial participants and research staff.
-
Like many of its counterparts, the IRB at New York State Psychiatric Institute (NYSPI) evaluates any complaint from a research participant on an individual, case-by-case basis. IRB Advisor spoke with Corinne Rogers, MS, CIP, NYSPI IRB director, to find out more about her research-related dispute procedures.
-
Data safety monitoring boards (DSMBs) have played a big role in delivering vaccines and treatments to the public faster in the past 18 months. DSMBs reviewed results and safety data of the various studies involving treatments and vaccines for COVID-19. IRB Advisor asked two scientists about how DSMB work has helped improve research protections during the pandemic.
-
An IRB process improvement project reduced the protocol modification time by half. The change required the IRB chairs to give up some of their responsibilities and put these new responsibilities on the IRB coordinators.
-
The results of a recent study indicate potential research participants are open to alternative vaccine trial designs, including challenge trials in which participants are exposed to COVID-19.
